[ 1 ] Klaassen C D. Heavy Metals and Heavy-Metal Antagonists. in :Goodman & Gilmanps The Pharmacological Basis of Therapeutics(Eds. Hardman J G, Gilman A G, Limbird L E) . New York :McGraw-Hill , 1996 , 1649 —1672
[ 5 ] Cutler E G, Bradford E H. Am. J . Med. Sci . , 1878 , 75 : 74 —84
[6]
[ 6 ] Forkner C E , Scott T FM. J . Am. Med. Assoc. , 1931 , 97 : 3 —5
[7]
[ 7 ] Lykknes A , Kvittingen L. J . Chem. Educ. , 2003 , 80 : 497 —500
[8]
[ 8 ] Levanson A S. J . Chem. Educ. , 1977 , 54 : 98 —99
[9]
[ 9 ] Lloyd N C , Morgan H W, Nicholson B K, et al . Angew. Chem.Int . Ed. , 2005 , 44 : 941 —944
[10]
[10 ] Tarnowski G S , Schmid F A , Cappuccino J G, et al . Cancer Res. ,1966 , 26 : 181 —206
[11]
[11 ] Chan P C , Huff J . J . Environ. Sci . Health Part C , 1997 , 15 : 83 —122
[12]
[12 ] Keiser J , Ericsson ; , Burri C. Clin. Pharmacol . & Ther. , 2000 ,67 : 478 —488
[13]
[13 ] Niu C , Yan H , Chen GQ , et al . Blood , 1991 , 94 : 3315 —3324
[14]
[14 ] Shen Z X, Chen G Q , Ni J H , et al . Blood , 1997 , 89 : 3354 —3360
[15]
[15 ] Zhang T D , Chen G Q , Wang Z G, et al . Oncogene , 2001 , 20 :7146 —7153
[16]
[16 ] Hu J , Fang J , Dong Y, et al . Anticancer Drugs , 2005 , 16 : 119 —127
[17]
[17 ] Waxman S , Anderson K C. Oncologist , 2001 , 6 : 3 —10
[18]
[18 ] Dilda P J , Hogg P J . Cancer Treatment Rev. , 2007 , 33 : 542 —564
[19]
[19 ] Wang Z G, Rivi R , Delva L , et al . Blood , 1998 , 92 : 1497 —1504
[20]
[20 ] Rousselot P , Larghero J , Labaume S , et al . Eur. J . Haematol . ,2004 , 72 : 166 —171
[21]
[21 ] Koshiuka K, Elstner E , Williamson E , et al . Br. J . Cancer , 2000 ,82 : 452 —458
[22]
[22 ] Gibaud S , Zirar S B , Mutzenhardt P , et al , Int . J . Pharm. , 2005 ,306 : 107 —121
[23]
[23 ] Thomas D J , Styblo M, Lin S. Toxicol . Appl . Pharmacol . , 2001 ,176 : 127 —144
[24]
[24 ] Duzkale H , Jilani I , Orsolic N , et al . Cancer Chemother.Pharmacol . , 2003 , 51 : 427 —432
[25]
[25 ] Don A S , Kisker O , Dilda P , et al . Cancer Cell , 2003 , 3 : 497 —509
[26]
[26 ] McStay G P , Clarke S J , Halestrap A P. Biochem. J . , 2002 , 367 :541 —548
[27]
[27 ] Golemovic M, Orsolic N , Zingaro R , et al . ASH Annual Meeting Abstract , 2003
[28]
[28 ] Kornblau S M, Jackson C E , Worthing A , et al . ASCO Annual Meeting Proceedings. 2006
[29]
[29 ] Reglinski J . Environmental and Medicinal Chemistry of Arsenic ,Antimony and Bismuth , in : Chemistry of Arsenic , Antimony and Bismuth , ( Ed. Norman N C) , London : Blavkie Academic & Professional , 1998
[30]
[30 ] Sun H , Zhang L , Szeto K Y. Metal Ions Biol . Syst . , 2004 , 41 :333 —378
[31]
[31 ] Zhu J , Chen Z, Lallemand-Breitenbach V. Nat . Rev. Cancer ,2002 , 2 : 705 —714
[32]
[32 ] Schmidt H , Peter F M. Advances in the Therapeutics of Antimony ,Leipzig : Thieme Verlag , 1938
[113 ] Turkez H , Geyikoglu F , Keles M S. Biol . Trace. Elem. Res. ,2005 , 105 : 151 —158
[114]
[114 ] Salaspuro M. Helicobacter Pylori Alcohol Dehydrogenase , in : Toward a Molecular Basis of Alcohol Use and Abuse , ( Eds. Jansson B ,Jêrnvall H , Rydberg U , Terenius L , Vallee B L) , Switzerland :Birkh? user Verlag , Basel , 1994 , 185 —195
[115]
[115 ] Jin L , Szeto K Y, Zhang L , et al . J . Inorg. Biochem. , 2004 , 98 :1331 —1337
[116]
[116 ] Mulrooney S B , Hausinger R P. FEMSMicrobiol . Rev. , 2003 , 27 :239 —261
[117]
[117 ] Zhang L , Mulrooney S B , Leung A F K, et al . BioMetals , 2006 ,19 : 503 —511